HTG MOLECULAR DIAGNOSTICS IN

CUSIP: 40434H104 Class: COM

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q3 2019
Shares 159,129 Value ($000) $106 Avg Close Range
Q2 2019
Shares 114,997 Value ($000) $191 Avg Close Range
Q1 2019
Shares 51,831 Value ($000) $130 Avg Close Range
Q4 2018
Shares 50,533 Value ($000) $128 Avg Close Range
Q3 2018
Shares 26,209 Value ($000) $132 Avg Close Range
Q2 2018
Shares 29,602 Value ($000) $97 Avg Close Range